Protein kinase tweak reprograms TB bacterium's nitric oxide response

Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), remains a major global killer because the bacterium can sense and adapt to changing conditions inside people. To survive in the lungs and inside immune cells, Mtb must respond to chemical signals such as nitric oxide (NO) and loss of oxygen (hypoxia). Two major signaling toolkits help the bacterium sense these cues: two-component systems (TCSs), which include response regulators like DosR, and serine/threonine protein kinases (STPKs). Both systems are abundant in Mtb— the bacterium has roughly equal numbers of STPKs (11) and TCSs (12)—but how they work together was unclear. In work led by Shumin Tan, researchers set out to see whether and how STPKs influence TCS function. They focused on the DosRS(T) TCS, a well-known regulator that turns on genes important when Mtb experiences NO and hypoxia. By examining interactions between the two signaling systems and what happens when DosR is chemically modified by STPKs, the team aimed to reveal fresh layers of control that help Mtb decide when to switch on protective programs and when to remain quiet.

The team found widespread cross-talk: multiple STPKs show interactions with TCS response regulators, and a subset of STPKs target DosR specifically. Crucially, STPK phosphorylation of DosR reduced DosR’s ability to bind its target promoter DNA and lowered its capacity to activate steady-state gene transcription. That outcome contrasts sharply with the activated, phospho-aspartic acid form of DosR, which produces the opposite effect and promotes gene activation. The functional consequence of STPK action was demonstrated in an engineered strain: a ΔSTPK Mtb mutant showed increased transcription of the DosR regulon at lower NO levels than wild type Mtb. In plain terms, when the STPK layer is missing, the DosRS(T) system turns on its genes more readily in response to NO. These results paint a picture in which STPK phosphorylation restrains and fine-tunes the conditions under which DosR-driven programs are fully activated.

The study supports a model in which STPKs and TCSs do not act in isolation but instead form an integrated signaling network that shapes Mtb’s response to hostile conditions. By dampening DosR’s promoter binding and transcriptional activation, STPK phosphorylation sets a threshold for when the DosRS(T) regulon should be engaged, preventing premature or excessive activation. This layered control may help Mtb balance energy use and stress responses as it navigates fluctuating NO and oxygen levels inside the host. For researchers, the finding highlights an additional regulatory checkpoint to consider when studying bacterial persistence and stress tolerance. While the work does not itself propose a therapy, understanding how STPKs tune TCS activity could guide future strategies to disrupt Mtb signaling, making the bacterium less adaptable to immune pressures and potentially more vulnerable to treatments or immune clearance.